Even though its increasing cash burn makes us a little nervous, we are compelled to mention that we thought Aadi Bioscience's cash runway was relatively promising. One real positive is that analysts are forecasting that the company will reach breakeven. We don't think its cash burn is particularly problematic, but after considering the range of factors in this article, we do think shareholders should be monitoring how it changes over time. Taking an in-depth view of risks, we've identified 2 warning signs for Aadi Bioscience that you should be aware of before investing.